Andrea Loewen-Rodriguez
Corporate Officer/Principal bij Retrophin Pharmaceutical, Inc.
Profiel
Andrea Loewen-Rodriguez is currently the Head-Global Regulatory Affairs at Shire Pharmaceuticals, Inc. and the Vice President-Global Regulatory Affairs at Retrophin Pharmaceutical, Inc. She previously worked as the Senior Director-Regulatory Affairs at Ceregene, Inc. from 2008 to 2009, Vice President-Global Regulatory Affairs at Reata Pharmaceuticals, Inc. from 2020 to 2023, Vice President-Global Regulatory Affairs & Quality at Vital Therapies, Inc., and Vice President-Global Regulatory Affairs & Quality at Travere Therapeutics, Inc. from 2017 to 2020.
She received her undergraduate degree from Gustavus Adolphus College and her graduate degree from Pepperdine University.
Actieve functies van Andrea Loewen-Rodriguez
| Bedrijven | Functie | Begin |
|---|---|---|
Retrophin Pharmaceutical, Inc.
 Retrophin Pharmaceutical, Inc. BiotechnologyHealth Technology Part of Travere Therapeutics, Inc., Retrophin Pharmaceutical, Inc. develops drugs to treat debilitating and often life-threatening diseases. | Corporate Officer/Principal | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Algemeen Adviseur | - |
Eerdere bekende functies van Andrea Loewen-Rodriguez
| Bedrijven | Functie | Einde |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Algemeen Adviseur | 26-09-2023 |
| TRAVERE THERAPEUTICS, INC. | Algemeen Adviseur | 01-01-2020 |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Algemeen Adviseur | 01-06-2009 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Algemeen Adviseur | - |
Opleiding van Andrea Loewen-Rodriguez
| Gustavus Adolphus College | Undergraduate Degree |
| Pepperdine University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Retrophin Pharmaceutical, Inc.
Retrophin Pharmaceutical, Inc. BiotechnologyHealth Technology Part of Travere Therapeutics, Inc., Retrophin Pharmaceutical, Inc. develops drugs to treat debilitating and often life-threatening diseases. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
